Brands Browse Interactions Pill ID Categories

Loading…

Drugvu is an independent compilation of publicly-disclosed pharmaceutical regulatory information. It is not affiliated with the FDA, EMA, MHRA, Health Canada, TGA, TİTCK, PMDA, or any pharmaceutical manufacturer or regulatory agency.

This is not medical advice. Always consult a qualified healthcare professional for medical decisions.

About Editorial process Editorial team Data sources Methodology Corrections Contribute Privacy Terms DMCA Contact

Larotrectinib and Pimecrolimus: Minor Interaction - Drugvu

🏠›Larotrectinib›Interaction with Pimecrolimus

Larotrectinib + Pimecrolimus

Drug interaction

Minor interaction

A minor drug-drug interaction between Larotrectinib and Pimecrolimus is recorded in public interaction data. Severity reflects the source classification; it does not describe your individual risk. Do not start, stop, or change either medicine based on this page.

What “minor” means

A minor interaction is usually of limited importance for most people, though it is still worth being aware of.

What to do

Usually no change is needed - but ask your pharmacist if you notice anything unusual.

The two medicines

Active ingredient

Larotrectinib

Other Protein Kinase Inhibitors

Uses, side effects, dosage →· 405 recorded interactions

Active ingredient

Pimecrolimus

Agents For Dermatitis, Excluding Corticosteroids

Uses, side effects, dosage →· 175 recorded interactions

Source

DDInter 2.0 (CC-BY 4.0, https://ddinter.scbdd.com)

This is not medical advice. Drugvu is an independent aggregator of public records.